Cell-mediated immunity and the outcome of hepatitis C virus infection
- PMID: 15487943
- DOI: 10.1146/annurev.micro.58.030603.123836
Cell-mediated immunity and the outcome of hepatitis C virus infection
Abstract
The hepatitis C virus (HCV) infects approximately three percent of the world's population. Some individuals resolve the infection spontaneously, but the majority develop persistent viremia that often causes progressive liver disease. There is an emerging consensus that cellular immune responses are essential for spontaneous resolution of acute hepatitis C and long-term protection from persistent infection. This review focuses on the recent advances in understanding mechanisms of protective immunity and why they fail in most infected individuals. The distinct yet complementary role of CD4+ and CD8+ T lymphocytes in this process is highlighted.
Similar articles
-
Virus-Specific Cellular Response in Hepatitis C Virus Infection.Arch Immunol Ther Exp (Warsz). 2016 Apr;64(2):101-10. doi: 10.1007/s00005-015-0364-8. Epub 2015 Oct 1. Arch Immunol Ther Exp (Warsz). 2016. PMID: 26429740 Review.
-
Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection.J Exp Med. 2003 Jun 16;197(12):1645-55. doi: 10.1084/jem.20030239. J Exp Med. 2003. PMID: 12810686 Free PMC article.
-
A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees.Nat Med. 2006 Feb;12(2):190-7. doi: 10.1038/nm1353. Epub 2006 Feb 5. Nat Med. 2006. PMID: 16462801
-
HCV persistence and immune evasion in the absence of memory T cell help.Science. 2003 Oct 24;302(5645):659-62. doi: 10.1126/science.1088774. Science. 2003. PMID: 14576438
-
Cellular immune responses against hepatitis C virus.Clin Infect Dis. 2005 Jul 1;41 Suppl 1:S25-31. doi: 10.1086/429492. Clin Infect Dis. 2005. PMID: 16265610 Review.
Cited by
-
T cell receptor variable β gene repertoire in liver and peripheral blood lymphocytes of chronically hepatitis C virus-infected patients with and without mixed cryoglobulinaemia.Clin Exp Immunol. 2013 May;172(2):254-62. doi: 10.1111/cei.12035. Clin Exp Immunol. 2013. PMID: 23574322 Free PMC article.
-
Structural basis for broad neutralization of hepatitis C virus quasispecies.PLoS One. 2011;6(10):e26981. doi: 10.1371/journal.pone.0026981. Epub 2011 Oct 26. PLoS One. 2011. PMID: 22046426 Free PMC article.
-
Effects of mutation number in interferon sensitivity determining region on peripheral blood CD4(+) T cell subsets (Th1, Th2) in chronic hepatitis C patients with hepatitis C virus genotype 1b and high viral load.Hepatol Int. 2012 Apr;6(2):468-74. doi: 10.1007/s12072-011-9305-8. Epub 2011 Aug 6. Hepatol Int. 2012. PMID: 21818686
-
Unsolved Puzzles Surrounding HCV Immunity: Heterologous Immunity Adds Another Dimension.Int J Mol Sci. 2017 Jul 27;18(8):1626. doi: 10.3390/ijms18081626. Int J Mol Sci. 2017. PMID: 28749434 Free PMC article. Review.
-
Regulation of hepatocyte fate by interferon-γ.Cytokine Growth Factor Rev. 2011 Feb;22(1):35-43. doi: 10.1016/j.cytogfr.2011.01.001. Epub 2011 Feb 18. Cytokine Growth Factor Rev. 2011. PMID: 21334249 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials